PubRank

H Niphuis

Author PubWeight™ 33.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys. AIDS 1991 1.99
2 Flow cytometric analysis on reactivity of human T lymphocyte-specific and cytokine-receptor-specific antibodies with peripheral blood mononuclear cells of chimpanzee (Pan troglodytes), rhesus macaque (Macaca mulatta), and squirrel monkey (Saimiri sciureus) J Med Primatol 1997 1.43
3 Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci U S A 1990 1.39
4 Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS 1995 1.34
5 Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques. J Virol 2000 1.26
6 The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 1993 1.10
7 Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retroviruses 1994 1.00
8 Seroprevalence of specific viral infections in confiscated orangutans (Pongo pygmaeus). J Med Primatol 1998 1.00
9 Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 1994 0.98
10 Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques. J Gen Virol 1999 0.97
11 Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology 1997 0.96
12 Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS 2001 0.95
13 Fatal Herpes simplex infection in a group of common marmosets (Callithrix jacchus). Vet Pathol 2003 0.95
14 Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection. Virology 1998 0.93
15 The interleukin-17 gene of herpesvirus saimiri. J Virol 1998 0.92
16 Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunol Lett 1996 0.92
17 Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination. J Gen Virol 1995 0.92
18 Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees. J Gen Virol 1998 0.90
19 Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol 2000 0.88
20 Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Infect Dis 1995 0.87
21 The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques. J Gen Virol 2000 0.85
22 The effect of recombinant human interferon alpha B/D compared to interferon alpha 2b on SIV infection in rhesus macaques. Antiviral Res 1996 0.85
23 T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology. J Virol 1998 0.84
24 Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J Exp Med 2001 0.84
25 Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines. J Med Primatol 1992 0.83
26 Infectivity and virulence of cell-associated SIVmac after single passage in vivo. AIDS 1994 0.81
27 An anti-HIV strategy combining chemotherapy and therapeutic vaccination. J Med Primatol 1999 0.80
28 Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques. AIDS 2001 0.79
29 Characterization of a simian T-lymphotropic virus from a wild-caught orang-utan (Pongo pygmaeus) from Kalimantan, Indonesia. J Gen Virol 1998 0.79
30 The role of major histocompatibility complex polymorphisms on SIV infection in rhesus macaques. Immunol Lett 1996 0.79
31 A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens. J Med Primatol 2000 0.77
32 Seroprevalence of SV40-like polyomavirus infections in captive and free-ranging macaque species. J Med Primatol 2008 0.77
33 Antibody-dependent cellular cytotoxicity to clinical isolates of HIV-1 and SIVcpz: comparison of human and chimpanzees. AIDS 1996 0.77
34 Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol 2001 0.76
35 Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune responses or vaccine efficacy. Vaccine 2005 0.76
36 Correlation of major histocompatibility complex with opportunistic infections in simian immunodeficiency virus-infected rhesus monkeys. Lab Invest 1997 0.75
37 Isolation of uninfected immature hematopoietic cells from bone marrow of simian immunodeficiency virus infected rhesus monkeys. Transplant Proc 1993 0.75